PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University of Cambridge, Cambridge, United Kingdom.\', \'Queen Mary University of London, London, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/prp2.653
?:doi
?:hasPublicationType
?:journal
  • Pharmacology research & perspectives
is ?:pmid of
?:pmid
?:pmid
  • 32930523
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Pharmacological hypothesis: TPC2 antagonist tetrandrine as a potential therapeutic agent for COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all